Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Replek

1945 FOUNDED
PUBLIC STATUS
401-500 EMPLOYEES
REPL STOCK SYMBOL
$1.42K SHARE PRICE (As of Monday Closing)
Description

Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Other Devices and Supplies
Stock Exchange
XMAE
Primary Office
  • Kozle st. 188
  • Skopje, 1000
  • Macedonia

+389 02 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Replek’s full profile, request a free trial.

Replek Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.31K - $1.42K $1.41K 18.43

Replek Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 32,317 26,858 19,416 18,679
Revenue 19,490 17,364 14,768 14,500
EBITDA 2,865 2,691 2,222 1,900
Net Income 2,465 2,348 1,939 1,649
Total Assets 34,809 29,954 30,332
Total Debt 0 1,218 1,567 1,174
Public Fundamental Data provided by Morningstar, Inc. disclaimer